""	"Rank"	"NCT.Number"	"Title"	"Status"	"Study.Results"	"Conditions"	"Interventions"	"Phases"	"Study.Type"	"Locations"	"URL"
"90"	90	"NCT04380688"	"Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19."	"Not yet recruiting"	"No Results Available"	"COVID-19"	"drug: acalabrutinib"	"Phase 2"	"Interventional"	"Research Site, Washington, District of Columbia, United States|Research Site, Louisville, Kentucky, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Hackensack, New Jersey, United States|Research Site, Buffalo, New York, United States"	"https://ClinicalTrials.gov/show/NCT04380688"
"91"	91	"NCT04346199"	"Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19."	"Not yet recruiting"	"No Results Available"	"COVID-19"	"drug: acalabrutinib"	"Phase 2"	"Interventional"	"Research Site, Bobigny, France|Research Site, Villejuif Cedex, France|Research Site, Bologna, Italy|Research Site, Firenze, Italy|Research Site, Milano, Italy|Research Site, Roma, Italy|Research Site, Roma, Italy|Research Site, Fuenlabrada, Spain|Research Site, Madrid, Spain|Research Site, Mérida, Spain|Research Site, Pozuelo de Alarcón, Spain"	"https://ClinicalTrials.gov/show/NCT04346199"
